2022

Twitter, as a company, underwent numerous changes in 2022, but for users, it largely remained the same old space. What Happened: There were several tweets that oozed wisdom and wit, and others with a tinge of humor that made the internet collectively giggle. Here’s a list of 12...

The year 2022 was tough for automakers as they had to contend with supply chain challenges and softening consumer demand. What Happened: Industry-wide auto sales fell 8% year-over-year to 13.7 million vehicles in 2022, reported The Wall Street Journal. This marked the lowest number since 2011....

2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like Apple Inc. (NASDAQ: AAPL) and Tesla Inc. (NASDAQ: TSLA) bit the dust, there were a...

Who could forget 2021 and the cryptocurrency craze? It was definitely the “Year of Dogecoin” (CRYPTO: DOGE) for Benzinga readers as the "Top 5 Articles" were about the memecoin. But, as 2022 crept in, multiple crypto industry controversies and failures — Bahamas-...

According to a recent study by Web 3 security firm Beosin, over $718 million were lost to Web 3-related schemes during the second quarter of 2022.  The report says 48 major “attacks” were responsible for the losses incurred. Each accounted for over $100 million in losses, with 28...

This article was originally published on WeedWeek and appears here with permission. The future is notoriously difficult to predict. A few souls responded to our call for industry predictions for 2022. But they were (mostly) self-serving and dull, so they’re not getting printed. Instead here...

According to a new blog post, Shiba Inu (CRYPTO: SHIB) developers have launched a beta version of a decentralized autonomous organization (DAO) called Doggy.  The DAO's mission is to give Shiba Inu holders more authority to decide on crypto projects. Doggy DAO will be run...

Cryptocurrency trader and analyst Michaël van de Poppe says Ethereum (CRYPTO: ETH) may very well become the focus of the next major crypto cycle in 2022.  In an end-of-year analysis, he said that the second-largest crypto by market cap could even top $20,000 and appears the...

During an end-of-year interview, senior currency strategist at Forex analysis site DailyFX Christopher Vecchio said that he would be very surprised if Shiba Inu (CRYPTO: SHIB) or Dogecoin (CRYPTO: DOGE) have a good 2022.   Adding that he believes that only Tesla Inc (NASDAQ...

There was a lot to celebrate in 2021, including the cryptocurrency market coming into its own and making millionaires seemingly overnight that balanced out the downside, such as the continuing COVID-19 pandemic. But, to be honest, we probably have been ready for 2022 for a while. A tradition that...

2021 may have been the Year of the Ox in the Chinese calendar, but for Benzinga, it was the Year of the Dog, or should we say, Year of the Dogecoin (CRYPTO: DOGE). The memecoin created in 2013 by Billy Markus and Jackson Palmer has finally shed its "joke" origins — Markus and Palmer...

Recent supply chain conditions set up the semiconductor sector for substantial revenue in 2022 with much of the growth coming from substantial restocking by customers, according to an analyst at Morgan Stanley. Here are the dominant themes for the sector in 2022, according to ...

The much-awaited Apple Inc (NASDAQ: AAPL) will launch its computerized glasses at the end of 2022; that's according to analyst Ming-chi Kuo.  Kuo says the glasses will run on MacBook chips, and the processing power will help the glasses stand out from competitors.  He indicates...

By The Fresh Toast's Brendan Bures, provided exclusively to Benzinga Cannabis. “I’ve seen some really large numbers in terms of the amount of cash flow that would come into the government as a result of just a normal excise tax regime.” State lawmakers have proposed...

By The Fresh Toast's Brendan Bures, provided exclusively to Benzinga Cannabis. MDMA-assisted psychotherapy is expected to receive FDA approval by 2022, following successful Phase 3 trials. The Food and Drug Administration (FDA) tapped MDMA as a “breakthrough therapy” to...